184241-36-9Relevant articles and documents
Spiro tetrahydroquinazolines and dihydrocyclopentapyrimidines as CRF antagonists
-
Page/Page column 15, (2010/02/11)
Compounds of the formula (I): and pharmaceutically acceptable salts or prodrugs thereof, wherein X, Y, Z and R1 are as defined herein. The invention also provides methods for preparing, compositions comprising, and methods for using compounds o
Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists
Chen,Dagnino R.,De Souza,Grigoriadis,Huang,Kim K.-,Liu,Moran,Webb,Whitten,Yun Feng Xie,McCarthy
, p. 4358 - 4360 (2007/10/03)
-